HOUSTON – Rheonix and Life Technologies said this week that they have entered into a joint development agreement to develop and market a version of Rheonix's integrated molecular testing platform for applied markets such as food safety.

For Rheonix, the agreement will serve as a springboard for its platform – the Chemistry and Reagent Device, or CARD, consumable and associated Encompass MDx system – into the clinical diagnostic market, company executives said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.